ENEDRA THERAPEUTICS LIMITED

Active Cambridge

Other research and experimental development on natural sciences and engineering

4 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
E

ENEDRA THERAPEUTICS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 2 Jun 2021 Active Cambridge, England 4 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 5 Sept 2025 Next due 30 Apr 2027 11 months remaining
Confirmation Submitted 23 Jun 2025 Next due 15 Jun 2026 27 days remaining
Net assets £55K £149K 2024 year on year
Total assets £694K £635K 2024 year on year
Total Liabilities £639K £486K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Salisbury House Station Road Cambridge CB1 2LA England

Email

info@example.com

Website

www.example.com

Full company profile for ENEDRA THERAPEUTICS LIMITED (13433538), an active life sciences and medical technology company based in Cambridge, England. Incorporated 2 Jun 2021. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

£90.37k

Increased by £55.24k (+157%)

Net Assets

£54.69k

Increased by £149.04k (+158%)

Total Liabilities

£639.02k

Increased by £486.04k (+318%)

Turnover

N/A

Employees

4

Increased by 1 (+33%)

Debt Ratio

92%

Decreased by 169 (-65%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

9 Allotments 73,114 Shares £970k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
6 Nov 202441,545£628k£15.121
14 Jun 20246,614£100k£15.121
23 May 202410,101£100k£9.9
23 May 2024512£0.512£0.001
19 Jul 20213,535£35k£9.901

Officers

Officers

2 active 1 resigned
Status
Patrick Christian Maurice ChaltinDirectorBelgianBelgium516 Nov 2024Active
Tanya Marie MooreDirectorBritishUnited Kingdom5115 Oct 2021Active

Shareholders

Shareholders (10)

Mr Andreas Ballis
32.4%
48,500
Ku Leuven Research & Development
23.8%
35,592

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Andreas Ballis

Greek

Active
Notified 2 Jun 2021
Residence United Kingdom
DOB July 1978
Nature of Control
  • Ownership Of Shares 50 To 75 Percent,voting Rights 50 To 75 Percent,right To Appoint And Remove Directors

Alexander Paul Gutteridge

Ceased 4 Mar 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
24 Dec 2025OfficersTermination of Laura Margaret Fletcher as director on 24 Dec 2025
5 Sept 2025AccountsAnnual accounts made up to 31 Jul 2025
4 Sept 2025OfficersAppointment of Dr Adrian Paul Ibrahim as director on 4 Sept 2025
4 Sept 2025AccountsAnnual accounts made up to 31 Oct 2025
4 Jul 2025AccountsAnnual accounts made up to 31 Oct 2024
24 Dec 2025 Officers

Termination of Laura Margaret Fletcher as director on 24 Dec 2025

5 Sept 2025 Accounts

Annual accounts made up to 31 Jul 2025

4 Sept 2025 Officers

Appointment of Dr Adrian Paul Ibrahim as director on 4 Sept 2025

4 Sept 2025 Accounts

Annual accounts made up to 31 Oct 2025

4 Jul 2025 Accounts

Annual accounts made up to 31 Oct 2024

Recent Activity

Latest Activity

Termination of Laura Margaret Fletcher as director on 24 Dec 2025

4 months ago on 24 Dec 2025

Annual accounts made up to 31 Jul 2025

8 months ago on 5 Sept 2025

Appointment of Dr Adrian Paul Ibrahim as director on 4 Sept 2025

8 months ago on 4 Sept 2025

Annual accounts made up to 31 Oct 2025

8 months ago on 4 Sept 2025

Annual accounts made up to 31 Oct 2024

10 months ago on 4 Jul 2025